Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAberd Asia Inc Regulatory News (AAIF)

Share Price Information for Aberd Asia Inc (AAIF)

Share Price is delayed by 15 minutes
Get Live Data
352.00    6.00 (1.73%)
Bid:
348.00
Ask:
357.00
Spread: 9.00 (2.586%)
Market Cap: £501.66m
AAIF Live PriceLast checked at - London Stock Exchange

Intraday Aberd Asia Inc Share Chart

Declaration of Second Interim Dividend

15 Jul 2025 10:07

RNS Number : 1232R
Aberdeen Asian Income Fund Limited
15 July 2025
 

Aberdeen Asian Income Fund Limited (the "Company")

Legal Entity Identifier (LEI): 549300U76MLZF5F8MN87

 

15 July 2025

 

Declaration of Second Interim Dividend

 

 

Highlights

 

· Annualised dividend yield of 6.8%.

· Second quarterly interim dividend of 3.84p per share.

 

The Board has declared a second quarterly interim dividend of 3.84p per share for the year ended 31 December 2025, which will be paid on 22 August 2025 to shareholders on the register at the close of business on 25 July 2025. The ex-dividend date is 24 July 2025.

 

Based on a share price of 223p on 30 June 2025, and taking into account the first interim dividend already paid, this equates to an annualised dividend yield of 6.8%.

 

This is the second dividend payment announced by the Company following the introduction of the enhanced dividend policy earlier this year, to broaden the appeal of the Company's shares to a wider range of investors and to reflect the sustained investor appetite for yield in the current interest rate environment.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ("DRIP"), which is managed by the Company's Registrar, Computershare Investor Services PLC. The deadline for elections under the DRIP is 1 August 2025.

 

Note:

The Company's dividend policy, as announced on 16 January 2025, is to set the dividend at 1.5625% per quarter of the Company's net asset value ("NAV"), equating to approximately 6.25% of NAV per annum. The dividend is calculated using the Company's NAV on the last business day of the preceding financial quarter (i.e. the end of March, June, September and December). The second quarterly interim dividend of 3.84p per share is based on 1.5625% of the Company's NAV of 246.02p per share as at 30 June 2025.

 

 

For further information, please contact:

 

Aberdeen (Investment Manager):

Ben Heatley, Head of Closed End Fund Sales

Ben.Heatley@aberdeenplc.com

 

Maria Allen, Client Director, Closed End Funds

Maria.Allen@aberdeenplc.com

 

Peel Hunt LLP (Corporate Broker):

Luke Simpson, Huw Jeremy (Investment Banking)

 

Alex Howe, Richard Harris (Sales)

 

020 7418 8900

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGCGDRLGBDGUU
Date   Source Headline
30th Dec 20241:01 pmRNSNet Asset Value(s)
27th Dec 202412:32 pmRNSNet Asset Value(s)
24th Dec 202412:41 pmRNSNet Asset Value(s)
23rd Dec 20241:10 pmRNSGearing disclosure
23rd Dec 202412:49 pmRNSNet Asset Value(s)
20th Dec 20241:14 pmRNSNet Asset Value(s)
19th Dec 20245:09 pmRNSTransaction in Own Shares
19th Dec 202412:33 pmRNSNet Asset Value(s)
18th Dec 20245:22 pmRNSTransaction in Own Shares
18th Dec 202411:58 amRNSNet Asset Value(s)
17th Dec 20245:13 pmRNSTransaction in Own Shares
17th Dec 202411:55 amRNSNet Asset Value(s)
16th Dec 20245:13 pmRNSTransaction in Own Shares
16th Dec 20243:09 pmRNSGearing disclosure
16th Dec 202412:56 pmRNSNet Asset Value(s)
13th Dec 20245:18 pmRNSTransaction in Own Shares
13th Dec 202412:16 pmRNSNet Asset Value(s)
12th Dec 20245:16 pmRNSTransaction in Own Shares
12th Dec 202412:04 pmRNSNet Asset Value(s)
11th Dec 20245:23 pmRNSPortfolio Disclosures
11th Dec 20245:16 pmRNSTransaction in Own Shares
11th Dec 202412:34 pmRNSNet Asset Value(s)
10th Dec 20245:31 pmRNSTransaction in Own Shares
10th Dec 202411:56 amRNSNet Asset Value(s)
9th Dec 20245:11 pmRNSTransaction in Own Shares
9th Dec 20242:09 pmRNSGearing disclosure
9th Dec 202412:52 pmRNSNet Asset Value(s)
6th Dec 20245:06 pmRNSTransaction in Own Shares
6th Dec 20241:43 pmRNSNet Asset Value(s)
5th Dec 20245:24 pmRNSTransaction in Own Shares
5th Dec 20243:21 pmRNSMonth End Net Asset Value(s)
5th Dec 202412:21 pmRNSNet Asset Value(s)
4th Dec 20245:18 pmRNSTransaction in Own Shares
4th Dec 20241:06 pmRNSNet Asset Value(s)
3rd Dec 20245:23 pmRNSTransaction in Own Shares
3rd Dec 202412:11 pmRNSNet Asset Value(s)
2nd Dec 20243:05 pmRNSGearing disclosure
2nd Dec 202410:08 amRNSTotal Voting Rights
29th Nov 202412:42 pmRNSNet Asset Value(s)
28th Nov 20245:09 pmRNSTransaction in Own Shares
28th Nov 202412:31 pmRNSNet Asset Value(s)
27th Nov 202412:12 pmRNSNet Asset Value(s)
26th Nov 20245:08 pmRNSTransaction in Own Shares
26th Nov 202412:57 pmRNSNet Asset Value(s)
25th Nov 20245:20 pmRNSTransaction in Own Shares
25th Nov 20243:46 pmRNSGearing Disclosures
25th Nov 202412:40 pmRNSNet Asset Value(s)
22nd Nov 20245:16 pmRNSTransaction in Own Shares
22nd Nov 20243:58 pmRNSDirector/PDMR Shareholding
22nd Nov 202412:20 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.